36 results on '"Rodolico, Daniele"'
Search Results
2. The Lure of Cardiac Metabolism in the Diagnosis, Prevention, and Treatment of Heart Failure
3. Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases
4. Comments on the myPACE Randomized Clinical Trial
5. Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge
6. Depression in Heart Failure with Reduced Ejection Fraction, an Undervalued Comorbidity: An Up-To-Date Review
7. Reply to: ‘What is the optimal dose of neurohormonal modulators in patients with heart failure? The higher the better?’
8. GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research
9. Use of and association between heart failure pharmacological treatments and outcomes in obese versus non‐obese patients with heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry
10. Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction
11. Ticagrelor Enhances Ischemic Pre-Conditioning in Stable Patients Undergoing Percutaneous Coronary Intervention: The Taper-S Randomized Study
12. Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge.
13. 695 PRESCRIBING A COMPREHENSIVE THERAPY WITH THE FOUR FOUNDATIONAL TREATMENTS OF HEART FAILURE WITH REDUCED EJECTION FRACTION AMONG IN-PATIENTS AT DISCHARGE
14. Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials
15. Cardiac metabolism in HFpEF: from fuel to signalling
16. Gender-differences in antithrombotic therapy across the spectrum of ischemic heart disease: Time to tackle the Yentl syndrome?
17. Molecular mechanisms underlying the beneficial effects of exercise and dietary interventions in the prevention of cardiometabolic diseases.
18. Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime
19. Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the S wedish Heart Failure Registry
20. Ticagrelor Induces Ischemic Preconditioning in Stable Patients Undergoing Percutaneous Coronary Intervention: The TAPER-S Randomized Study
21. Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of ST-elevation myocardial infarction.
22. Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials
23. Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry.
24. Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19–Negative Patients?
25. Metabolic inflammation in heart failure with preserved ejection fraction
26. Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond
27. Experience of remote cardiac care during the COVID‐19 pandemic: the V‐LAP™ device in advanced heart failure
28. Novel Basic Science Insights to Improve the Management of Heart Failure: Review of the Working Group on Cellular and Molecular Biology of the Heart of the Italian Society of Cardiology
29. Metabolic inflammation in heart failure with preserved ejection fraction.
30. Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
31. Colchicine in Patients with Chronic Coronary Disease: TO THE EDITOR.
32. Cardiac metabolism in HFpEF: from fuel to signalling
33. GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research.
34. Cardiac metabolism in HFpEF: from fuel to signalling.
35. Adenosine as adjunctive therapy in acute coronary syndrome: a meta-analysis of randomized controlled trials.
36. Telemedicine, Artificial Intelligence and Humanisation of Clinical Pathways in Heart Failure Management: Back to the Future and Beyond.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.